MOCPAC

• CAT Number: I041315
• CAS Number: 787549-26-2
• Molecular Formula: C27H31N3O6
• Molecular Weight: 493.55
• Purity: ≥95%
• Synonyms: benzyl N-[(2S)-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxo-6-(propanoylamino)hexan-2-yl]carbamate
• InChI: InChI=1S/C27H31N3O6/c1-3-24(31)28-14-8-7-11-22(30-27(34)35-17-19-9-5-4-6-10-19)26(33)29-20-12-13-21-18(2)15-25(32)36-23(21)16-20/h4-6,9-10,12-13,15-16,22H,3,7-8,11,14,17H2,1-2H3,(H,28,31)(H,29,33)(H,30,34)/t22-/m0/s1
• InChIKey: BFDGUJKFQRJHJM-QFIPXVFZSA-N
• SMILES: CCC(=O)NCCCC[C@@H](C(=O)NC1=CC2=C(C=C1)C(=CC(=O)O2)C)NC(=O)OCC3=CC=CC=C3

MOCPAC（Cat No.:I041315）is a novel small molecule compound being investigated for its potential therapeutic applications in cancer treatment. It works by targeting and inhibiting specific proteins involved in tumor cell survival and proliferation, particularly those associated with cell cycle regulation and DNA repair mechanisms. By blocking these pathways, MOCPAC aims to suppress tumor growth and enhance the effectiveness of existing chemotherapy regimens. Preclinical studies have shown promising results, suggesting that MOCPAC could offer a new approach to treating aggressive cancers, with potential for improved outcomes and reduced side effects compared to current therapies.